Briumvi’s Phase 3 trial of an at-home injection has completed enrollment, testing an under-the-skin version against IV ...
The first biosimilars referencing Humira became available in 2023. That year, 10 FDA-approved adalimumab are now on the ...
Gut bacteria aren’t just passive passengers—they can actively send proteins straight into our cells. Using microscopic injection systems, even harmless microbes can influence immune responses and ...
If you could inject yourself with a substance that purports to make you tanner, fitter and healthier, would you? Many people are saying “yes.” Online, social media influencers tout vials of substances ...
“No, I haven't decided,” Self said in the postgame news conference at Viejas Arena. “I'll get back and visit with family. I've had obviously some issues off the court health-wise. And that will be ...
Our Verdict: DirectMeds offers one of the most accessible NAD+ injection programs in the telehealth space. With LegitScript certification, 180,000+ customers, a 4.6-star Trustpilot rating, and ...
While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...
Researchers boosted levels of a heart-healing hormone in mice and pigs with a single injection of a new, experimental form of self-amplifying RNA that prolonged hormone synthesis for many weeks. When ...
China to inject 300 billion yuan into state banks Beijing launches 100 billion yuan fund to boost domestic demand China to step up tech financing, deepen capital markets "Green channel" to fast-track ...
AbbVie had 10 therapies with sales of $1 billion or more each in 2025. The pharma giant has raised its dividends annually for 54 consecutive years. AbbVie has a large pipeline of mid- and late-stage ...
Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo Nordisk in the obesity drug race. While Novo’s shares have struggled this ...